Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-11-15Clinical Trial Update: Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH [NA]
The clinical trial NCT02759549 investigating fatigue in breast cancer patients undergoing radiotherapy (eSMART-MH) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer [Phase 4]
This clinical trial update indicates that the Phase 4 PRIMADOS study evaluating Avastin (bevacizumab) plus docetaxel as first-line treatment…
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX) [Phase 4]
Phase 4 AVATAX trial evaluating first-line bevacizumab with paclitaxel for locally recurrent or metastatic HER2-negative breast cancer has b…
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 study of trastuzumab with bevacizumab and sequential capecitabine or docetaxel in HER2-positive locally recurrent or metastatic brea…
-
CLINICAL_TRIALS withdrawal · 2016-10-27Clinical Trial Update: Pectoral Nerve Blockade in Mastectomy [Phase 4]
Phase 4 clinical trial evaluating pectoral nerve blockade for postoperative pain after mastectomy has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-10-26Clinical Trial Update: Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab [Phase 1, Phase 2]
The Phase 1/2 trial of trastuzumab in combination with AMG 479 for HER-2 overexpressing metastatic breast cancer progressing on trastuzumab …
-
CLINICAL_TRIALS withdrawal · 2016-10-21Clinical Trial Update: Treatment of Benign Breast Deformities and Post-Segmental Mastectomy Breast Deformities With Autologous Fat Grafting (AFT) [NA]
A University of Pittsburgh trial evaluating autologous fat grafting to treat benign breast deformities and deformities after segmental maste…
-
CLINICAL_TRIALS withdrawal · 2016-10-13Clinical Trial Update: Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy [Phase 2]
A Phase 2 trial evaluating the omission of sentinel node biopsy in breast cancer patients planning adjuvant chemotherapy has been withdrawn.…
-
CLINICAL_TRIALS withdrawal · 2016-09-30Clinical Trial Update: Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers [Phase 4]
Phase 4 trial of vortioxetine for major depressive disorder, cognition, and systemic inflammatory biomarkers in breast cancer patients was w…
-
CLINICAL_TRIALS withdrawal · 2016-09-14Clinical Trial Update: Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial of trastuzumab emtansine in patients with HER2-equivocal breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-31Clinical Trial Update: Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer [NA]
A clinical trial evaluating chemotherapy for elderly patients with localized HER2-positive breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-12Clinical Trial Update: A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029) [Phase 3]
A Phase 3 trial evaluating MK0822 for reducing bone metastasis risk in women with breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: Whole-body MRI for the Detection of Metastasis
A clinical trial evaluating whole-body MRI to detect metastasis in breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-03Clinical Trial Update: Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders [NA]
A clinical trial evaluating acupuncture for post-mastectomy patients with tissue expanders has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-01Clinical Trial Update: Effects of a Group Residential Retreat on Cancer Outcomes [NA]
A clinical trial evaluating the effects of a group residential retreat on outcomes in breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-20Clinical Trial Update: Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers [NA]
A Stanford University-sponsored trial investigating iodine-131 radiopharmaceutical therapy for breast cancers detected by 124I PET/CT has be…
-
CLINICAL_TRIALS withdrawal · 2016-07-12Clinical Trial Update: Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating docetaxel in combination with St. John's Wort for solid tumors that cannot be removed surgically has been withdra…
-
CLINICAL_TRIALS withdrawal · 2016-07-12Clinical Trial Update: Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer [Phase 3]
A Phase 3 trial evaluating trastuzumab with or without tamoxifen in women with progressive Stage IV breast cancer has been withdrawn from cl…
-
CLINICAL_TRIALS withdrawal · 2016-07-11Clinical Trial Update: Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer
The clinical trial NCT00934401 evaluating positron emission mammography using fluorothymidine (FLT) to assess chemotherapy response in breas…
-
CLINICAL_TRIALS withdrawal · 2016-05-30Clinical Trial Update: A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer [NA]
A pilot preoperative trial of ganetespib with paclitaxel for triple-negative breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-03Clinical Trial Update: Chemotherapy-Induced Peripheral Neuropathy Survey
A clinical trial evaluating chemotherapy-induced peripheral neuropathy has been withdrawn. The study involved patients with breast cancer, c…
-
CLINICAL_TRIALS withdrawal · 2016-04-15Clinical Trial Update: Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer [Phase 2]
A Phase 2 neoadjuvant study of ACE (doxorubicin/cyclophosphamide followed by eribulin) for operable HER2-negative breast cancer has been wit…
-
CLINICAL_TRIALS withdrawal · 2016-02-24Clinical Trial Update: Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy
Withdrawal notice for a trial evaluating how frequently portal imaging should be used to enhance quality assurance for breast cancer radioth…
-
CLINICAL_TRIALS withdrawal · 2016-02-23Clinical Trial Update: The Use of Metformin in Early Breast Cancer Patients Pre-Surgery [EARLY_Phase 1]
A Phase 1 study investigating metformin in patients with early breast cancer prior to surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: TORI 104 Pre-Surgical Dasatinib [Phase 2]
A Phase 2 trial of pre-surgical dasatinib for breast cancer (TORI 104) has been withdrawn.